Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection-Reference-Cited by-同舟云学术

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection

Published:2017-11-24 Issue:2 Volume:67 Page:505-513
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Toyoda Hidenori¹,Chayama Kazuaki²,Suzuki Fumitaka³,Sato Ken⁴,Atarashi Tomofumi⁵,Watanabe Tsunamasa⁶,Atsukawa Masanori⁷,Naganuma Atsushi⁸,Notsumata Kazuo⁹,Osaki Yukio¹⁰,Nakamuta Makoto¹¹,Takaguchi Koichi¹²,Saito Satoru¹³,Kato Koji¹⁴,Pugatch David¹⁴,Burroughs Margaret¹⁴,Redman Rebecca¹⁴,Alves Katia¹⁴,Pilot‐Matias Tami J.¹⁴,Oberoi Rajneet K.¹⁴,Fu Bo¹⁴,Kumada Hiromitsu³

Affiliation:

1. Ogaki Municipal HospitalOgaki Japan

2. Hiroshima University HospitalHiroshima Japan

3. Toranomon HospitalTokyo Japan

4. Gunma University HospitalMaebashi Japan

5. JA Hokkaido P.W.F.A.C. Obihiro‐Kosei General HospitalObihiro Japan

6. St. Marianna University SchoolKawasaki Japan

7. Nippon Medical School Chiba Hokusoh HospitalInzai Japan

8. NHO Takasaki General Medical CenterTakasaki Japan

9. Fukuiken Saiseikai HospitalFukui Japan

10. Osaka Red Cross HospitalOsaka Japan

11. NHO Kyushu Medical CenterFukuoka Japan